15 results
dm2 inhibitors summary medications agonists dosing dpp4 glp1 metformin oral adverseeffects cardiovascular combination combo comparison inpatient management mechanism mellitus mnemonic
Cardiovascular and renal effects comparison between SGLT-2 inhibitors - Canagliflozin (Invokana) - Dapagliflozin (Farxiga) - Empagliflozin
Cardiovascular and renal ... comparison between SGLT ... (Steglatro) #diabetes ... #SGLT2i #Inhibitors ... #pharmacology
Diabetes Combination Tablets - Estimated A1c Lowering Metformin + DPP4 • Janumet (metformin + sitagliptin) •
Diabetes Combination ... Metformin + SGLT2 ... /ambcarerx #Diabetes ... Tablets #Oral #DM2 #Pharmacology ... #Pills #Endocrinology
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
- Pharmacology ... of use) Common Side ... • Euglycemic diabetic ... #Summary #DM2 #diabetes ... #endocrinology
Mechanism of Action for Common Diabetes Medications • SGLT2i (Dapagliflozin) • TZD (Pioglitazone) • Biguanides (Metformin)
Action for Common Diabetes ... Medications • SGLT2i ... sarahthelyon #Diabetes ... #Medications #pharmacology ... pathophysiology #endocrinology
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... class of anti-diabetic ... #Inhibitors #Pharmacology ... Medications #DM2 #Diabetes ... #Endocrinology
TACROLIMUS - Side Effects Mnemonic Tremor Alopecia Cardiovascular (HTN) Renal insufficiency Oncologic (Skin Cancer) Lipids (hyperlipidemia) Insulin
TACROLIMUS - Side ... Cardiovascular (HTN) Renal ... Insulin dependent diabetes ... Seizures #Pharmacology
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... receptor agonist, SGLT2i ... insulin dose for renal ... #Medications #pharmacology ... comparison #table #endocrinology
Sulfonylureas - Pharmacology Summary Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... in CKD Common Side ... Sulfonylureas #Pharmacology ... #Summary #DM2 #diabetes ... #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Inhibitors - Normal and Renal ... with only few side ... #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... disease Common Side ... #Metformin #Pharmacology ... #Summary #DM2 #diabetes ... #endocrinology
No results found for "Wide pocus pharmacology pulmonaryembolism diabetes sglt2 renal endocrinology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Wide #pocus #pharmacology #pulmonaryembolism #diabetes #sglt2 #renal #endocrinology